首页> 中文期刊> 《中国药理学报:英文版》 >Population pharmacokinetics of modafinil acid and estimation of the metabolic conversion of modafinil into modafinil acid in 5 major ethnic groups of China

Population pharmacokinetics of modafinil acid and estimation of the metabolic conversion of modafinil into modafinil acid in 5 major ethnic groups of China

         

摘要

Aim:To describe the population pharmacokinetic profile of modafinil acid and to compare the extent of metabolism of modaflnil into modafinil acid in 5 major ethnic groups (Han,Mongolian,Korean,Uygur,and Hui) of China.Methods:In a multi-center,open-label,single dose clinical trial,49 healthy volunteers from the 5 ethnic groups received 200 mg of modafinil orally.Blood samples for pharmacokinetic evaluation of modafinil and modafinil acid were drawn before and at different time after the administration.Systematic population pharmacokinetic (PopPK) modeling for modafinil acid was conducted,integrating with our previous PopPK model for modafinil.The influence of ethnicity,gender,height,body weight and body mass index (BMI) was estimated.The extent of metabolism of modafinil into modafinil acid,expressed as the relative conversion fraction,was estimated and compared among the 5 ethnic groups.Results:When combined with the PopPK model of modafinil,the concentration of modafinil acid versus time profile was best described with a one-compartment model.The typical clearance and volume of distribution for modafinil acid were 4.94 (l/h) and 2.73 (l),respectively.The Korean group had 25% higher clearance,and the Uygur and Hui groups had 12% higher clearance than the Han group.The median for the relative conversion fraction was 0.53 for Koreans,and 0.24 for the other 4 ethnicities.Conclusion:Ethnicity has significant influence on the clearance of modafinil acid.When patients in the 5 ethnic groups are administered drugs or prodrugs catalyzed by esterases and/or amidases,the variability in the extent of drug metabolism should be considered.

著录项

  • 来源
    《中国药理学报:英文版》 |2012年第11期|1401-1408|共8页
  • 作者单位

    State Key Laboratory of Natural and Biomimetic Drugs(Peking University),Beijing 100191,China;

    Department of Medicine,University of Chicago,Chicago 60616,USA;

    Department of Pharmacy,Shenyang Northern Hospital,Shenyang 110016,China;

    Department of Pharmaceutics,School of Pharmaceutical Sciences,Peking University Health Science Center,Beijing 100191,China;

    Department of Pharmaceutics,School of Pharmaceutical Sciences,Peking University Health Science Center,Beijing 100191,China;

    State Key Laboratory of Natural and Biomimetic Drugs(Peking University),Beijing 100191,China;

    Department of Pharmaceutics,School of Pharmaceutical Sciences,Peking University Health Science Center,Beijing 100191,China;

    State Key Laboratory of Natural and Biomimetic Drugs(Peking University),Beijing 100191,China;

    Department of Pharmaceutics,School of Pharmaceutical Sciences,Peking University Health Science Center,Beijing 100191,China;

    State Key Laboratory of Natural and Biomimetic Drugs(Peking University),Beijing 100191,China;

    Department of Pharmaceutics,School of Pharmaceutical Sciences,Peking University Health Science Center,Beijing 100191,China;

  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号